Relay Therapeutics, Inc. RLAY Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $204.59M+119% | $84.02M-32.4% | $91.56M-39.9% | $113.94M-15.0% | $93.54M-38.8% | ||
| $1.34M-37.0% | $1.34M-37.0% | $2.26M+6.6% | $2.26M-16.6% | $2.12M-21.7% | ||
| $11.84M-46.1% | $17.79M+2.5% | $23.84M+27.3% | $16.04M+58.5% | $21.95M+66.5% | ||
| $658.46M-11.0% | $578.28M-28.5% | $624.01M-27.9% | $680.39M-3.4% | $739.66M-4.0% | ||
| $1.22M-76.3% | $1.73M-70.8% | $2.36M-67.3% | $3.46M-58.6% | $5.15M-47.9% | ||
| $38.59M-23.0% | $39.99M-22.7% | $41.37M-22.5% | $42.73M-22.2% | $50.14M-11.2% | ||
| $437.48M-29.1% | $470.5M-28.4% | $504.87M-26.5% | $542.83M-2.1% | $616.81M+3.4% | ||
| $699.61M-12.5% | $621.33M-28.7% | $670M-28.0% | $728.84M-5.7% | $799.36M-5.0% | ||
| $847K-49.6% | $463K-76.7% | $1.08M-20.5% | $609K-20.7% | $1.68M+1.2% | ||
| $3.89M-34.4% | $3.77M-34.3% | $3.64M-34.1% | $3.53M-33.9% | $5.93M+15.2% | ||
| $29.75M-19.7% | $25.58M-49.6% | $32.61M-30.6% | $32.53M-27.8% | $37.05M-0.2% | ||
| $27.68M-32.9% | $28.69M-32.9% | $29.69M-33.0% | $30.66M-33.0% | $41.23M-12.6% | ||
| $57.43M-26.6% | $54.27M-42.0% | $62.29M-31.7% | $63.18M-30.4% | $78.28M-18.2% | ||
| —— | —— | —— | —— | —— | ||
| $182K+8.3% | $168K0.0% | $168K+0.6% | $168K+26.3% | $168K+27.3% | ||
| $2.73B+7.6% | $2.58B+2.5% | $2.57B+2.7% | $2.55B+13.0% | $2.54B+13.8% | ||
| -$2.09B-15.0% | -$2.01B-15.9% | -$1.96B-17.9% | -$1.89B-19.8% | -$1.82B-22.5% | ||
| -$172K-553% | $733K+174% | $493K-80.4% | -$163K+87.8% | $38K+103% | ||
| $642.18M-10.9% | $567.06M-27.1% | $607.71M-27.6% | $665.66M-2.4% | $721.08M-3.3% | ||
| $699.61M-12.5% | $621.33M-28.7% | $670M-28.0% | $728.84M-5.7% | $799.36M-5.0% | ||
| $4.56M-37.9% | $5.97M-43.3% | $3.74M-44.9% | $7.58M+32.2% | $7.35M+0.7% | ||
| $38.59M-23.0% | $39.99M-22.7% | $41.37M-22.5% | $42.73M-22.2% | $50.14M-11.2% | ||
| $437.48M-29.1% | $470.5M-28.4% | $504.87M-26.5% | $542.83M-2.1% | $616.81M+3.4% | ||
| $38.59M-23.0% | $39.99M-22.7% | $41.37M-22.5% | $42.73M-22.2% | $50.14M-11.2% | ||
| $38.59M-23.0% | $39.99M-22.7% | $41.37M-22.5% | $42.73M-22.2% | $50.14M-11.2% | ||
| $20.91M-0.4% | $13.65M-35.7% | $25.13M-24.3% | $23.22M-16.4% | $20.99M-6.1% | ||
| $20.91M-0.4% | $13.65M-35.7% | $25.13M-24.3% | $23.22M-16.4% | $20.99M-6.1% | ||
| $847K-49.6% | $463K-76.7% | $1.08M-20.5% | $609K-20.7% | $1.68M+1.2% | ||
| $31.57M-33.1% | $32.46M-33.1% | $33.33M-33.1% | $34.18M-33.1% | $47.16M-9.8% | ||
| $182K+8.3% | $168K0.0% | $168K+0.6% | $168K+26.3% | $168K+27.3% | ||
| $11.84M-46.1% | $17.79M+2.5% | $23.84M+27.3% | $16.04M+58.5% | $21.95M+66.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Relay Therapeutics, Inc.'s total assets?
- Relay Therapeutics, Inc. (RLAY) holds $699.6M in total assets, down 12.5% year over year.
- How much debt does Relay Therapeutics, Inc. have?
- Relay Therapeutics, Inc. carries $31.6M in total debt against $642.2M of shareholders' equity, a debt-to-equity ratio of 0.05.
- How much cash does Relay Therapeutics, Inc. have?
- Relay Therapeutics, Inc. holds $204.6M in cash and equivalents.
- Can Relay Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 22.13 — current assets exceed current liabilities.
- Where does Relay Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
